Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Adherium Ltd. ( (AU:ADR) ) is now available.
Adherium Limited announced the resolution of a delay in the allotment and issue of new shares and options under its Institutional Entitlement Offer, which was caused by a settlement issue with an overseas investor. The allotment is now scheduled for 3 July 2025, with no changes to the remaining timetable of the Entitlement Offer. This development ensures the continuation of the company’s fundraising efforts, potentially impacting its financial stability and market operations.
More about Adherium Ltd.
Adherium is a leading provider of integrated digital health solutions and a global leader in connected respiratory medical devices. The company has sold over 180,000 devices worldwide and offers the Hailie® platform, which allows clinicians, healthcare providers, and patients to monitor medication usage and adherence remotely. The platform supports reimbursement for patient management and includes tools for data capture and sharing via apps, SDK, and API integration, along with a range of sensors for respiratory medications.
Technical Sentiment Signal: Sell
Current Market Cap: A$8.98M
Find detailed analytics on ADR stock on TipRanks’ Stock Analysis page.